Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor

Neuropharmacology

Volumn 37, Issue 12, 1998, Pages 1645-1647

  Hermans, E ^a,b   Nahorski, S R ^a   Challiss, R A J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

CPCCOEt; Glutamate; mGlu1 receptor; Non competitive antagonist; Phosphoinositide hydrolysis

Indexed keywords

7 (HYDROXYIMINO)CYCLOPROPAN[B]CHROMEN 1A CARBOXYLIC ACID ETHYL ESTER; METABOTROPIC RECEPTOR; PHOSPHATIDYLINOSITIDE; UNCLASSIFIED DRUG;

CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROLYSIS; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0032403074     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00132-4     Document Type: Article

References (11)

1. Annoura H., Fukunaga A., Uesuga M., Tatsuoka T., Horikawa Y. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino) cyclopropa[b]chromen-1a-carboxylate. Bioorg. Med. Chem. Lett. 6:1996;763-766.
2. Carruthers A.M., Challiss R.A.J., Mistry R., Saunders R., Thomsen C., Nahorski S.R. Enhanced type 1α metabotropic glutamate receptor-stimulated phosphoinositide signalling after pertussis toxin treatment. Mol. Pharmacol. 52:1997;406-414.
3. Casabona G., Knöpfel T., Kuhn R.et al. Expression and coupling to phosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain. Eur. J. Neurosci. 9:1997;12-17.
4. Challiss R.A.J., Jenkinson S., Mistry R., Batty I.H., Nahorski S.R. Assessment of neuronal phosphoinositide turnover and its disruption by lithium. Neuroprotocols. 3:1993;135-144.
5. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
6. Dixon, M., Webb, E.C., 1979. Enzymes, 2nd ed. Longmans, London, pp. 16-31.
7. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (RS)-2-chloro-hydroxy-5-phenylglycine (CHPG) activates mGlu5, but not mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
8. 2+ signalling in an inducible cell expression system. J. Neurochem. 70:1998;1772-1775.
9. Moroni F., Lombardi G., Thomsen C.et al. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
10. Okamoto T., Sekiyama N., Otsu M.et al. Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 273:1998;13089-13096.
11. Watkins J.C., Collingridge G.L. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci. 15:1994;333-342.